Vertex Pharmaceuticals Aktie
461,75
EUR
-1,90
EUR
-0,41
%
505,11
USD
+0,36
USD
+0,07
%
nachbörslich
Werbung
Vertex Pharmaceuticals Aktie Analyse
14.12.12 | Vertex Pharmaceuticals sell | Goldman Sachs Group Inc. | |
05.11.12 | Vertex Pharmaceuticals sell | Goldman Sachs Group Inc. | |
04.01.08 | Vertex Pharmaceuticals underperform | Wachovia Sec | |
14.12.06 | Vertex Pharmaceuticals sell | Banc of America Sec. | |
21.11.05 | Vertex Pharmaceuticals Sell | Banc of America Sec. |
Werbung
Werbung